Literature DB >> 26304655

The 6-hydroxydopamine model and parkinsonian pathophysiology: Novel findings in an older model.

D Hernandez-Baltazar1, L M Zavala-Flores2, A Villanueva-Olivo3.   

Abstract

The neurotoxin 6-hydroxydopamine (6-OHDA) is widely used to induce models of Parkinson's disease (PD). We now know that the model induced by 6-OHDA does not include all PD symptoms, although it does reproduce the main cellular processes involved in PD, such as oxidative stress, neurodegeneration, neuroinflammation, and neuronal death by apoptosis. In this review we analyse the factors affecting the vulnerability of dopaminergic neurons as well as the close relationships between neuroinflammation, neurodegeneration, and apoptosis in the 6-OHDA model. Knowledge of the mechanisms involved in neurodegeneration and cell death in this model is the key to identifying potential therapeutic targets for PD.
Copyright © 2014 Sociedad Española de Neurología. Publicado por Elsevier España, S.L.U. All rights reserved.

Entities:  

Keywords:  Apoptosis; Estrés oxidativo; Neurodegeneración; Neurodegeneration; Neuroinflamación; Neuroinflammation; Nigrostriatal pathway; Oxidative stress; Substantia nigra; Vía nigroestriatal

Mesh:

Substances:

Year:  2015        PMID: 26304655     DOI: 10.1016/j.nrl.2015.06.011

Source DB:  PubMed          Journal:  Neurologia        ISSN: 0213-4853            Impact factor:   3.109


  34 in total

1.  Betanin Attenuates Oxidative Stress Induced by 6-OHDA in PC12 Cells via SAPK/JNK and PI3 K Pathways.

Authors:  Elham Hadipour; Masoud Fereidoni; Zahra Tayarani-Najaran
Journal:  Neurochem Res       Date:  2019-12-19       Impact factor: 3.996

2.  Dopaminergic Neuronal Death in Substantia Nigra Associates with Serum Levels of Total Bilirubin, Selenium, and Zinc: Evidences from 6-Hydroxydopamine Animal Model of Parkinson's Disease.

Authors:  Mohammad Sophiabadi; Nafiseh Rastgoo; Hashem Haghdoost-Yazdi
Journal:  Biol Trace Elem Res       Date:  2021-11-06       Impact factor: 4.081

Review 3.  Neuroinflammatory responses in Parkinson's disease: relevance of Ibuprofen in therapeutics.

Authors:  Ashish Singh; Pratibha Tripathi; Sarika Singh
Journal:  Inflammopharmacology       Date:  2020-10-14       Impact factor: 4.473

4.  Pramipexole attenuates 6-OHDA-induced Parkinson's disease by mediating the Nurr1/NF-κB pathway.

Authors:  Hua Gao; Dan Wang; Yu-Ling Wang; Jie-Ping Mao; Sen Jiang; Xin-Ling Yang
Journal:  Mol Biol Rep       Date:  2021-04-23       Impact factor: 2.316

Review 5.  The Path to Progress Preclinical Studies of Age-Related Neurodegenerative Diseases: A Perspective on Rodent and hiPSC-Derived Models.

Authors:  Gabriella MacDougall; Logan Y Brown; Boris Kantor; Ornit Chiba-Falek
Journal:  Mol Ther       Date:  2021-01-09       Impact factor: 11.454

Review 6.  Brain regions susceptible to alpha-synuclein spreading.

Authors:  Yu-Jie Guo; Huan Xiong; Kang Chen; Jin-Jun Zou; Peng Lei
Journal:  Mol Psychiatry       Date:  2021-09-24       Impact factor: 15.992

7.  Tocotrienols Ameliorate Neurodegeneration and Motor Deficits in the 6-OHDA-Induced Rat Model of Parkinsonism: Behavioural and Immunohistochemistry Analysis.

Authors:  Mangala Kumari; Premdass Ramdas; Ammu Kutty Radhakrishnan; Methil Kannan Kutty; Nagaraja Haleagrahara
Journal:  Nutrients       Date:  2021-05-10       Impact factor: 5.717

8.  Sudden death in a rat model of Parkinson's disease.

Authors:  Fulvio Alexandre Scorza; Laís Damasceno Rodrigues; Leandro Freitas Oliveira; Antônio Carlos G de Almeida; Josef Finsterer; Marcelo A Moret; Giancarlo de Mattos Cardillo; Carla Alessandra Scorza
Journal:  Clinics (Sao Paulo)       Date:  2021-06-14       Impact factor: 2.365

9.  Sympathetic Denervation Alters the Inflammatory Response of Resident Muscularis Macrophages upon Surgical Trauma and Ameliorates Postoperative Ileus in Mice.

Authors:  Shilpashree Mallesh; Reiner Schneider; Bianca Schneiker; Mariola Lysson; Patrik Efferz; Eugene Lin; Wouter J de Jonge; Sven Wehner
Journal:  Int J Mol Sci       Date:  2021-06-26       Impact factor: 5.923

10.  Propolis as A Potential Disease-Modifying Strategy in Parkinson's Disease: Cardioprotective and Neuroprotective Effects in the 6-OHDA Rat Model.

Authors:  Valeria C Gonçalves; Daniel J L L Pinheiro; Tomás de la Rosa; Antônio-Carlos G de Almeida; Fúlvio A Scorza; Carla A Scorza
Journal:  Nutrients       Date:  2020-05-26       Impact factor: 5.717

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.